LS
Life Sciences Partners
Private EquityActiveLSP (Life Sciences Partners) is a leading independent European investment firm, providing financing to private and public life-science
117
Investments
8
Exits
$1.8B
AUM
6.8%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Life Sciences Partners.
Investment Thesis & Strategy
LSP is a European private equity firm that invests in various stages of biotech, fintech, and healthcare companies. They focus on providing financing to both private and public life-science companies.
Investment Activity
Deals per year over the last 10 years
2
20080
20092
20100
20112
20120
20130
20142
20153
20161
2017Portfolio Companies
Selected investments from their portfolio of 117 companies
L
LAVA Therapeutics
Biotech · Series A, 2017
N
NorthSea Therapeutics
Biotech · Series A, 2016
I
Inflazome
Biotech · Series A, 2016
V
VarmX
Biotech · Series A, 2016
H
Hookipa Pharma
Biotech · Series A, 2015
N
NLC
Biotech · Growth, 2015
A
Acerta Pharma
Biotech · Series B, 2012
P
ProQR Therapeutics
Biotech · Series A, 2012
M
Mendus
Biotech · Series A, 2010
M
Merus
Biotech · Series A, 2010
L
Lead Pharma
Biotech · Series A, 2008
A
AM-Pharma
Biotech · Series B, 2008
Notable Exits
CompanyTypeYearValue / Acquirer
Agomab TherapeuticsAcquisition2024—
AM-PharmaAcquisition2023$1.75B
Hookipa PharmaIPO2019$100M
ObsEvaIPO2017$100M
MerusIPO2016$100M
ProQR TherapeuticsIPO2015$100M
uniQureIPO2012$150M
Innate PharmaIPO2006—
Frequently Asked Questions
Life Sciences Partners focuses on Series B, Series C+ stage investments.
Related Investors
Holland Venture
Amsterdam, The Netherlands · 43 deals
NPM Capital
Amsterdam, The Netherlands · 22 deals
AlpInvest Partners
Amsterdam, The Netherlands · 18 deals
Axivate Capital
Amsterdam, The Netherlands · 15 deals
XSML
Amsterdam, The Netherlands · 12 deals
Avedon Capital Partners
Amsterdam, The Netherlands · 11 deals